Blog Posts in June, 2017


    The U.S. Food and Drug Administration (The FDA) issued a Black Box Warning regarding Invokana® in May of 2017. This warning was sent to physicians and the medical community to address two recently published, independent studies indicating that patients prescribed the Type 2 Diabetes drug, Invokana® (also Invokamet® and Invokamet XR®) had two times the likelihood of needing toe, foot or leg ...
    Continue Reading
  • Supreme Court Decision Against Bristol-Myers Squibb

    The US Supreme Court recently rendered a decision in the California State Court action involving several plaintiffs against Bristol-Myers Squibb that may impact how individuals who have been injured by defective products can bring suit against these large corporate manufacturers. Below is a link to that opinion: https://www.supremecourt.gov/opinions/16pdf/16-466_1qm1.pdf In Bristol-Myers Squibb ...
    Continue Reading
Page 1 of 1